Bruker (BRKRP) Profit After Tax Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.27% |
| Dec 31, 2025 | -11.69% |
| Sep 30, 2025 | -25.05% |
| Jun 30, 2025 | -29.55% |
| Mar 31, 2025 | 10.63% |
| Dec 31, 2024 | -27.54% |
| Sep 30, 2024 | -7.83% |
| Jun 30, 2024 | -27.13% |
| Mar 31, 2024 | 11.12% |
| Dec 31, 2023 | 21.24% |
| Sep 30, 2023 | 15.37% |
| Jun 30, 2023 | 12.85% |
| Mar 31, 2023 | 23.45% |
| Dec 31, 2022 | 98.28% |
| Sep 30, 2022 | 19.03% |
| Jun 30, 2022 | 16.17% |
| Mar 31, 2022 | 23.52% |
| Dec 31, 2021 | 0.99% |
| Sep 30, 2021 | 13.63% |
| Jun 30, 2021 | 32.27% |
| Mar 31, 2021 | 19.62% |
| Dec 31, 2020 | 2.33% |
| Sep 30, 2020 | 36.20% |
| Jun 30, 2020 | 2.02% |
| Mar 31, 2020 | 10.07% |
| Dec 31, 2019 | 21.32% |
| Sep 30, 2019 | 62.07% |
| Jun 30, 2019 | 17.67% |
| Mar 31, 2019 | 28.68% |
| Dec 31, 2018 | 17.28% |
| Sep 30, 2018 | 21.19% |
| Jun 30, 2018 | 6.38% |
| Mar 31, 2018 | 37.97% |
| Dec 31, 2017 | -17.77% |
| Sep 30, 2017 | -1.40% |
| Jun 30, 2017 | 18.77% |
| Mar 31, 2017 | 7.42% |
| Dec 31, 2016 | 12.03% |
| Sep 30, 2016 | 18.62% |
| Jun 30, 2016 | -8.08% |
| Mar 31, 2016 | 15.87% |
| Dec 31, 2015 | 15.40% |
| Sep 30, 2015 | -15.81% |
| Jun 30, 2015 | -0.63% |
| Mar 31, 2015 | -16.59% |